The aim of this phase II, multicentre, randomized controlled trial was to evaluate the
effectiveness of a comprehensive oral management protocol for the prevention of severe …

The aim of these meta-analyses was to evaluate the effectiveness of interventions for the
prevention of oral mucositis in cancer patients treated with head and neck radiotherapy …

Objective: In order to prevent and treat radiation-induced adverse events, especially oral
mucositis, in patients with oral or oropharyngeal cancer receiving radiotherapy or …

Purpose This multicenter phase II trial assessed the clinical benefit of a multidisciplinary oral
care program in reducing the incidence of severe chemoradiotherapy-induced oral …

Objectives The objective of this network meta-analysis is to optimize the prophylactic
treatment for radiotherapy-induced oral mucositis in patients with head and neck cancer …

Mucositis significantly affects quality of life and tolerance of treatment in oral irradiation.
Effective management of this complication is therefore very important. However, there is a …

Purpose: To identify, classify, and evaluate agents used in the prophylaxis of oral mucositis
in irradiated head and neck cancer patients. Methods: Data sources included multiple …

Oral mucositis is a dose-limiting toxic effect of radiotherapy and chemotherapy on oral
cancer. The purpose of the present study is to assess the relationship between tumor …

The administration of many chemo-radiotherapy regimens in patients with cancer may be
complicated by toxicities that limit the clinicians' abilities to deliver the most effective doses of …

Oral mucositis is a distressing toxic effect of systemic chemotherapy with many commonly
utilized drugs and of head and neck irradiation in patients with cancer. The agents and …